"10.1371_journal.pone.0150083","plos one","2016-02-26T00:00:00Z","Alice Ossoli; Edward B Neufeld; Seth G Thacker; Boris Vaisman; Milton Pryor; Lita A Freeman; Christine A Brantner; Irina Baranova; Nicolás O Francone; Stephen J Demosky; Cecilia Vitali; Monica Locatelli; Mauro Abbate; Carlamaria Zoja; Guido Franceschini; Laura Calabresi; Alan T Remaley","Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy; Lipoprotein Metabolism Section, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America; NHLBI Electron Microscopy Core Facility, National Institutes of Health, Bethesda, Maryland, United States of America; Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy","Conceived and designed the experiments: AO EBN BV LC ATR. Performed the experiments: AO EBN SGT MP LAF CB IB NOF SJD CV ML MA CZ. Analyzed the data: AO EBN SGT BV LAF IB NOF SJD CV ML MA CZ GF LC ATR. Contributed reagents/materials/analysis tools: AO EBN BV MP LAF CB IB SJS CV ML MA CZ. Wrote the paper: EBN AO LC ATR.","The study received funding from MedImmune, Inc. as a CRADA-NIH Grant. The authors used a rhLCAT that is covered by the NIH patent The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis, WO 1997017434 A2. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Alice Ossoli","AO",17,TRUE,5,13,15,4,TRUE,TRUE,FALSE,0,NA,FALSE
